CRH Medical Corp. engages in the provision of gastroenterologists with services and products for the treatment of gastrointestinal diseases. It operates through the following business segments: Anesthesia Services, Product Sales, and Other. It also offers the CRH O'Regan System, which focuses on physician education, patient outcomes, and patient awareness. The Other segment covers the corporate activities. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Company profile
Ticker
CRHM
Exchange
Website
CEO
Edward Wright
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
CRH Anesthesia Management LLC • Gastroenterology Anesthesia Associates LLC • CRH Anesthesia of Gainesville LLC • CRH Anesthesia of Florida LLC • CRH Anesthesia of Cape Coral LLC • CRH Anesthesia of Knoxville LLC • CRH Anesthesia of Colorado, LLC • Alamo Sedation Associates LLC • Shreveport Sedation Associates, LLC • CRH Anesthesia of Ohio, LLC ...
CRHM stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
4 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 21
8-K
WELL Health Completes Acquisition of CRH Medical
28 Apr 21
25-NSE
Exchange delisting
23 Apr 21
Transcripts
CRHM
Earnings call transcript
2020 Q3
13 Nov 20
CRHM
Earnings call transcript
2020 Q2
11 Aug 20
CRHM
Earnings call transcript
2020 Q1
13 May 20
CRHM
Earnings call transcript
2019 Q4
12 Mar 20
CRHM
Earnings call transcript
2019 Q3
8 Nov 19
CRHM
Earnings call transcript
2019 Q2
4 Aug 19
CRHM
Earnings call transcript
2019 Q1
5 May 19
CRHM
Earnings call transcript
2018 Q4
14 Mar 19
CRHM
Earnings call transcript
2018 Q3
5 Nov 18
CRHM
Earnings call transcript
2018 Q2
4 Aug 18
Latest ownership filings
Financial summary
Quarter (USD) | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.92 mm | 3.92 mm | 3.92 mm | 3.92 mm | 3.92 mm | 3.92 mm |
Cash burn (monthly) | 393.25 k | 220.75 k | 7.87 mm | 2.89 mm | (no burn) | (no burn) |
Cash used (since last report) | 15.58 mm | 8.75 mm | 311.88 mm | 114.53 mm | n/a | n/a |
Cash remaining | -11.66 mm | -4.83 mm | -307.96 mm | -110.61 mm | n/a | n/a |
Runway (months of cash) | -29.6 | -21.9 | -39.1 | -38.3 | n/a | n/a |
Institutional ownership, Q4 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|